Philips Expands its Women's Healthcare Portfolio

Royal Philips ElectronicsRoyal Philips Electronics (AEX: PHI, NYSE: PHG) has agreed to acquire the mammography equipment product line of Sectra AB (NASDAQ OMX Stockholm: SECT B), a Swedish provider of medical systems and secure communication systems. With this acquisition Philips will broaden its product portfolio with a unique digital mammography solution that enables breast screening with less burden to women in terms of X-ray radiation dose.

Under the terms of the agreement, Philips will pay a cash consideration of EUR 57.5 million to acquire Sectra's mammography equipment business on a cash and debt-free basis. The agreement also includes an additional possible earn-out of EUR 12.5 million in accordance with specific terms and conditions. Approximately 110 people are expected to transfer with the business. The closing of the transaction, which is subject to certain contractual and other closing conditions, is expected in the third quarter of 2011.

"We strive to advance patient care by improving the timely detection of many of today's deadly diseases, including breast cancer," said Steve Rusckowski, CEO of Philips Healthcare. "The investment in this advanced digital mammography technology marks an important step in the execution of Philips' strategy to expand its Woman Healthcare portfolio with a wider range of screening digital mammography systems."

Digital mammography has proven to be a powerful diagnostic tool for the early detection of breast cancer, a disease that killed 458,000 women globally in 2010. The technology uses X-rays that are detected digitally and helps a doctor to identify abnormalities in breast tissue.

Sectra's MicroDose Mammography solution will complement Philips' offering in digital mammography and delivers high quality breast images while exposing women to up to 50 percent less X-ray radiation dose than other digital mammography systems. Moreover, the MicroDose Mammography technology offers opportunities for future innovative imaging solutions that provide information beyond 2D anatomical breast images.

Related news articles:

About Royal Philips Electronics
Royal Philips Electronics of the Netherlands (NYSE: PHG, AEX: PHI) is a diversified health and well-being company, focused on improving people's lives through timely innovations. As a world leader in healthcare, lifestyle and lighting, Philips integrates technologies and design into people-centric solutions, based on fundamental customer insights and the brand promise of "sense and simplicity". Headquartered in the Netherlands, Philips employs about 117,000 employees with sales and services in more than 100 countries worldwide. With sales of EUR 22.3 billion in 2010, the company is a market leader in cardiac care, acute care and home healthcare, energy efficient lighting solutions and new lighting applications, as well as lifestyle products for personal well-being and pleasure with strong leadership positions in male shaving and grooming, portable entertainment and oral healthcare.

Most Popular Now

AI Catches One-Third of Interval Breast …

An AI algorithm for breast cancer screening has potential to enhance the performance of digital breast tomosynthesis (DBT), reducing interval cancers by up to one-third, according to a study published...

Great plan: Now We need to Get Real abou…

The government's big plan for the 10 Year Health Plan for the NHS laid out a big role for delivery. However, the Highland Marketing advisory board felt the missing implementation...

Researchers Create 'Virtual Scienti…

There may be a new artificial intelligence-driven tool to turbocharge scientific discovery: virtual labs. Modeled after a well-established Stanford School of Medicine research group, the virtual lab is complete with an...

From WebMD to AI Chatbots: How Innovatio…

A new research article published in the Journal of Participatory Medicine unveils how successive waves of digital technology innovation have empowered patients, fostering a more collaborative and responsive health care...

New AI Tool Accelerates mRNA-Based Treat…

A new artificial intelligence (AI) model can improve the process of drug and vaccine discovery by predicting how efficiently specific mRNA sequences will produce proteins, both generally and in various...

Can Amazon Alexa or Google Home Help Det…

Computer scientists at the University of Rochester have developed an AI-powered, speech-based screening tool that can help people assess whether they are showing signs of Parkinson’s disease, the fastest growing...

AI also Assesses Dutch Mammograms Better…

AI is detecting tumors more often and earlier in the Dutch breast cancer screening program. Those tumors can then be treated at an earlier stage. This has been demonstrated by...

RSNA AI Challenge Models can Independent…

Algorithms submitted for an AI Challenge hosted by the Radiological Society of North America (RSNA) have shown excellent performance for detecting breast cancers on mammography images, increasing screening sensitivity while...

AI could Help Emergency Rooms Predict Ad…

Artificial intelligence (AI) can help emergency department (ED) teams better anticipate which patients will need hospital admission, hours earlier than is currently possible, according to a multi-hospital study by the...

Head-to-Head Against AI, Pharmacy Studen…

Students pursuing a Doctor of Pharmacy degree routinely take - and pass - rigorous exams to prove competency in several areas. Can ChatGPT accurately answer the same questions? A new...

NHS Active 10 Walking Tracker Users are …

Users of the NHS Active 10 app, designed to encourage people to become more active, immediately increased their amount of brisk and non-brisk walking upon using the app, according to...

The Human Touch of Doctors will Still be…

AI-based medicine will revolutionise care including for Alzheimer’s and diabetes, predicts a technology expert, but it must be accessible to all patients. Healing with Artificial Intelligence, written by technology expert Daniele...